首页 | 本学科首页   官方微博 | 高级检索  
检索        

白花前胡提取物对缺氧性肺动脉高压病人血浆内皮素—1的影响
引用本文:王秋月,康健,李尔然,于润江.白花前胡提取物对缺氧性肺动脉高压病人血浆内皮素—1的影响[J].中国医科大学学报,2001,30(1):28-30.
作者姓名:王秋月  康健  李尔然  于润江
作者单位:中国医科大学呼吸疾病研究所,
摘    要:目的:探讨内皮素-1(endothelin-1,ET-1)在慢性缺氧必肺动脉高压发生中的作用及白花前胡提取物(QF-8)降低肺动脉高压作用机制。方法:分别用右心漂浮导管法和放射免疫法同步检测11例慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)继发性肺动脉高压患者口服QF-8前、后血流动力学指标和体静脉、肺动脉及体动脉血浆ET-1水平。结果:COPD患者体静脉ET-1水平显著高于正常对照组体静脉(P<0.01)、自身肺动脉(P<0.05)及自身体动脉(P<0.01)血浆ET-1水平,且血浆(包括体静脉、肺动脉及体动脉)ET-1水平均与PaO2呈显著负相关,与肺血管阻力指数(pulmonary vascular resistance index,PVRI)呈显著正相关。口服QF-8后,肺动脉压力和PVRI明显下降,同时血浆ET-1水平亦呈不同程度下降,其下降幅度依次为体静脉(25%)>肺动脉(21%)>体动脉(10%),与血浆ET-1水平升高顺序一致。结论:ET-1的合成或分泌功能异常可能参与了慢性缺氧性肺动脉高压的形成,QF-8降低肺动脉高压作用与抑制ET-1成或分泌的某些环节有关。

关 键 词:缺氧  慢性阻塞性肺疾病  肺动脉高压  白花前胡提取物  内皮素-1
修稿时间:1999年11月11

Effect of Extract from Baihua Qianhu on the Plasma Endothelin-1 in Patients with Hypoxic Pulmonary Hypertension
Wang Qiuyue,Kang Jian,Li Erran,Yu Runjiang.Effect of Extract from Baihua Qianhu on the Plasma Endothelin-1 in Patients with Hypoxic Pulmonary Hypertension[J].Journal of China Medical University,2001,30(1):28-30.
Authors:Wang Qiuyue  Kang Jian  Li Erran  Yu Runjiang
Abstract:Objective: Our aim was to study the effect of endothelin-1 (ET-1) on the development of chronic hypoxic pulmonary hypertension and mechanism of QF-8 (the extract of baihua qianhu, a Chinese traditional medicine) in lowering pulmonary hypertension. Methods: The indexes of hemodynamics and the levels of plasma ET-1 in systemic vein, pulmonary artery, and systemic artery in 11 patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease (COPD) were measured with right-heart catheterization and radioimmunoassay. Results: The ET-1 level in patients was significantly higher in systemic vein than that in 15 controls (P<0.01), pulmonary artery (P<0.05), and systemic artery (P<0.01). The levels of plasma ET-1 in patients had significant negative correlation with PaO2 and positive correlation with pulmonary vascular resistance index (PVRI). After taking QF-8, mean pulmonary artery pressure (mPAP) and PVRI significantly decreased, meanwhile, the levels of plasma ET-1 in systemic vein, pulmonary artery, and systemic artery also decreased by 25%, 21%, and 10%, respectively. Conclusion: Abnormality in synthesis or secretion of ET-1 may play a role in the development of chronic hypoxic pulmonary hypertension. The effect of QF-8 on pulmonary hypertension in patients with COPD may be related with its inhibition on the synthesis or secretion of ET-1.
Keywords:qianhu  hypoxemia  chronic obstructive pulmonary disease  pulmonary hypertension
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号